Philipp Wolf

3.7k total citations
82 papers, 2.4k citations indexed

About

Philipp Wolf is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Philipp Wolf has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Immunology. Recurrent topics in Philipp Wolf's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Toxin Mechanisms and Immunotoxins (15 papers) and Prostate Cancer Treatment and Research (14 papers). Philipp Wolf is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Toxin Mechanisms and Immunotoxins (15 papers) and Prostate Cancer Treatment and Research (14 papers). Philipp Wolf collaborates with scholars based in Germany, United States and Austria. Philipp Wolf's co-authors include Ursula Elsässer‐Beile, Marta Michalska, Patrick Bühler, A. Katzenwadel, Ulrich Wetterauer, Axel Schoeniger, Dorothee Gierschner, Frank Edlich, Karen Alt and Wolfgang Schultze‐Seemann and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Nature Chemistry.

In The Last Decade

Philipp Wolf

74 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Wolf Germany 27 1.0k 526 503 477 420 82 2.4k
David Zopf United States 27 1.6k 1.5× 452 0.9× 469 0.9× 260 0.5× 219 0.5× 68 3.0k
Kiyoshi Ito Japan 28 1.4k 1.3× 236 0.4× 259 0.5× 197 0.4× 449 1.1× 167 3.2k
Yohan Kim United States 35 1.1k 1.1× 512 1.0× 576 1.1× 156 0.3× 335 0.8× 141 3.8k
Xiaofeng Lu China 32 1.4k 1.4× 537 1.0× 278 0.6× 350 0.7× 430 1.0× 165 3.3k
Iltefat Hamzavi United States 51 731 0.7× 1.3k 2.4× 365 0.7× 625 1.3× 329 0.8× 249 8.5k
Zhiyu Chen China 21 871 0.8× 342 0.7× 411 0.8× 293 0.6× 432 1.0× 119 2.2k
Semi Kim South Korea 30 1.9k 1.8× 432 0.8× 181 0.4× 176 0.4× 559 1.3× 108 3.5k
Jiayi Ding China 21 942 0.9× 571 1.1× 242 0.5× 131 0.3× 189 0.5× 56 2.0k
Hiroko Tada Japan 26 1.3k 1.3× 362 0.7× 223 0.4× 192 0.4× 358 0.9× 71 2.8k

Countries citing papers authored by Philipp Wolf

Since Specialization
Citations

This map shows the geographic impact of Philipp Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Wolf more than expected).

Fields of papers citing papers by Philipp Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Wolf. The network helps show where Philipp Wolf may publish in the future.

Co-authorship network of co-authors of Philipp Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Wolf. A scholar is included among the top collaborators of Philipp Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Wolf. Philipp Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Philipp, et al.. (2025). Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer. Antibodies. 14(1). 5–5. 2 indexed citations
2.
Storz, J., Philipp R. Esser, Stefan F. Martin, et al.. (2024). A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapy. Bioactive Materials. 41. 537–552. 5 indexed citations
3.
Wolf, Philipp. (2024). Dread-Disease-Versicherung: Trend Krebsversicherung. Forum. 39(2). 123–125.
4.
Storz, J., et al.. (2024). Photoimmunotherapy of HER2-expressing Breast Cancer Cells. Cancer Genomics & Proteomics. 21(4). 361–367.
5.
Kleinau, Gunnar, Robert Opitz, Patrick Scheerer, et al.. (2024). Melanocortin-4 Receptor PLC Activation Is Modulated by an Interaction with the Monocarboxylate Transporter 8. International Journal of Molecular Sciences. 25(14). 7565–7565.
6.
Fischer, Alexandra, et al.. (2023). Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer. Journal of Cancer. 14(16). 3039–3049. 1 indexed citations
7.
Monaco, Gianni, et al.. (2023). Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861. Frontiers in Pharmacology. 14. 1211824–1211824. 3 indexed citations
8.
Gratzke, Christian, et al.. (2022). Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies. Frontiers in Oncology. 12. 935715–935715. 22 indexed citations
9.
Wolf, Philipp, Axel Schoeniger, & Frank Edlich. (2022). Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(10). 119317–119317. 114 indexed citations
10.
Schreiber, Wolfgang, et al.. (2021). Managementstrategie für den Massenanfall von Erkrankten/Infizierten in Alten- und Pflegeheimen im Kontext der COVID-19-Pandemie. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 117(4). 289–296. 2 indexed citations
11.
Fischer, Alexandra, et al.. (2021). Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder Cancer. Anticancer Research. 41(8). 3741–3746. 6 indexed citations
12.
Wolf, Philipp, Jamal Alzubi, Christian Gratzke, & Toni Cathomen. (2021). The potential of CAR T cell therapy for prostate cancer. Nature Reviews Urology. 18(9). 556–571. 38 indexed citations
13.
Fischer, Alexandra, et al.. (2020). Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer. Toxins. 12(12). 753–753. 15 indexed citations
14.
Dittmar, Michael S., et al.. (2018). Primary mass casualty incident triage: evidence for the benefit of yearly brief re-training from a simulation study. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 26(1). 35–35. 23 indexed citations
15.
Michalska, Marta, et al.. (2018). Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells. Anticancer Research. 38(3). 1369–1375. 12 indexed citations
16.
Wolf, Philipp. (2017). BH3 Mimetics for the Treatment of Prostate Cancer. Frontiers in Pharmacology. 8. 557–557. 11 indexed citations
17.
Liu, Jihua, Pavla Kopečková, Huaizhong Pan, et al.. (2012). Prostate‐Cancer‐Targeted N‐(2‐Hydroxypropyl)methacrylamide Copolymer/Docetaxel Conjugates. Macromolecular Bioscience. 12(3). 412–422. 9 indexed citations
18.
Rosenberg, Efraim H., Lígia S. Almeida, Tjitske Kleefstra, et al.. (2010). Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database. European Journal of Human Genetics. 19(1). 56–63. 15 indexed citations
19.
Alt, Karen, Stefan Wiehr, Walter Ehrlichmann, et al.. (2010). High‐resolution animal PET imaging of prostate cancer xenografts with three different 64Cu‐labeled antibodies against native cell‐adherent PSMA. The Prostate. 70(13). 1413–1421. 41 indexed citations
20.
Elsässer‐Beile, Ursula, Gerald Reischl, Stefan Wiehr, et al.. (2009). PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen. Journal of Nuclear Medicine. 50(4). 606–611. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Zopf Breakdown of academic impact, for papers by Kiyoshi Ito Breakdown of academic impact, for papers by Yohan Kim Breakdown of academic impact, for papers by Xiaofeng Lu Breakdown of academic impact, for papers by Iltefat Hamzavi Breakdown of academic impact, for papers by Zhiyu Chen Breakdown of academic impact, for papers by Semi Kim Breakdown of academic impact, for papers by Jiayi Ding Breakdown of academic impact, for papers by Hiroko Tada
Rankless by CCL
2026